Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine Use in Intracranial Atherosclerotic Disease
NCT05503225Phase 2Recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Nov 2022
- Primary completion
- Sep 2027
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in intracranial atherosclerotic disease (ICAD), sponsored by The Chinese University of Hong Kong. Started Nov 2022; status: recruiting.
02
Drugs
colchicine
03
Conditions
intracranial atherosclerotic disease (ICAD)
Beyond the preview
Go deeper on NCT05503225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05503225.